Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “antibody”

426 pharma patents match "antibody" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 426
Index total 30,257
Page 3 / 18

Quick answer

This filtered view shows 426 pharmaceutical patents matching "antibody" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

426 results for “antibody” · 30,257 patents in full index Clear search

  1. US 12173084

    Phosphorylated dicer antibody and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  2. US 12173079

    Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

    Dyne Therapeutics, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  3. US 12168054

    Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody

    Syndax Pharmaceuticals, Inc. · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  4. US 12161717

    CD38 modulating antibody agents

    BLACK BELT THERAPEUTICS LIMITED · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  5. US 12162937

    Methods of treating an inflammatory disorder by administering an antibody which binds to a connexin CX43 hemichannel

    The Board of Regents of the University of Texas System · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  6. US 12162949

    CD38 antibody

    BLACK BELT THERAPEUTICS LIMITED · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  7. US 12156870

    Antibody drug conjugates comprising sting agonists

    Mersana Therapeutics, Inc. · Granted Dec 3, 2024 · Expires Nov 28, 2044

    granted
  8. US 12144869

    Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates

    Sutro Biopharma, Inc. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  9. US 12139543

    Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR

    CytomX Therapeutics, Inc. · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  10. US 12134631

    Hydrophilic linkers for antibody drug conjugates

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 5, 2024 · Expires Oct 31, 2044

    granted
  11. US 12121542

    BCMA chimeric antigen receptor based on single domain antibody and use thereof

    SHENZHEN PREGENE BIOPHARMA CO., LTD. · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  12. US 12090201

    Methods for treating atopic dermatitis by administering an IL-4R antagonist antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  13. US 12091463

    Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)

    Orionis Biosciences, Inc · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  14. US 12084490

    Antibody based reagents that specifically recognize toxic oligomeric forms of tau

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  15. US 12084516

    Anti-C5 antibody combinations and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  16. US 12084403

    Linkers for antibody drug conjugates

    The Board of Regents of the University of Texas System · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  17. US 12077572

    Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  18. US 12071477

    Anti-folate receptor alpha antibody conjugated with hemiasterlins

    Sutro Biopharma, Inc. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  19. US 12070506

    Steroids and antibody-conjugates thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  20. US 12054556

    Anti-PD-L1 antibody and use thereof

    Oricell Therapeutics Co., Ltd. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  21. US 12053526

    Methods for treatment using anti-alpha4beta7 antibody

    Takeda Pharmaceutical Company Limited · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  22. US 12054537

    Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies

    Inovio Pharmaceuticals, Inc. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  23. US 12043660

    10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  24. US 12029788

    Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibitor that is an anti-GDF8 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted